NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16.

Pastrana, D V

NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16. [electronic resource] - Virology Jan 2001 - 361-9 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article

0042-6822

10.1006/viro.2000.0702 doi


Antibodies, Viral--blood
Cross Reactions
Humans
Immunization
Neutralization Tests
Papillomaviridae--classification
Papillomavirus Infections--prevention & control
Phylogeny
Serotyping
Tumor Virus Infections--prevention & control
Viral Vaccines--administration & dosage
Virion--immunology
Virus Assembly